Lung
Cancer Diagnostics Market research
report displays key data and information about several factors which helps
achieve success in the competitive marketplace. Summary of the market is
analysed with respect to market players who are mainly customers, businesses or
clients. SWOT analysis is the standard, prominent and full-proof method to
perform the market research study which is used to formulate this particular Global
Lung Cancer Diagnostics Market report. To be ahead of the competition, a
systematic idea about the competitive landscape, their product range, their
strategies, and future prospects are very important. Market risks and entry
barriers makes Healthcare industry aware and help deciding further moves.
The global lung cancer diagnostics market is supportive
and aims to reduce the progression of the disease. Data Bridge Market Research
analyses that the global lung cancer diagnostics market will grow at a CAGR of
14.2% during the forecast period of 2023 to 2030.
Download Sample PDF
of Global Lung Cancer Diagnostics Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lung-cancer-diagnostics-market
Market Definition
Cancer begins in the lungs and most often occurs in people
who smoke. Two major types of lung cancer are non-small cell lung cancer and
small cell lung cancer. Causes of lung cancer include smoking, second-hand
smoke, exposure to certain toxins, and family history.
Symptoms include a cough (often with blood), chest pain,
wheezing, and weight loss. These symptoms often don't appear until the cancer
is advanced. Treatments vary but may include surgery, chemotherapy, radiation
therapy, targeted drug therapy, and immunotherapy.
Recent Developments
·
In October 2022, Quest Diagnostics announced a
new chapter of the partnership with Decode Health. This partnership has aided
the business in decreasing the time and expense involved in creating fresh
diagnostic tests and finding new medication targets for various cancers and
increased the company's global presence
·
In August 2022, F. Hoffmann-La Roche Ltd.
announced the launch of a Digital LightCycler System, a next-generation digital
PCR system that helps clinical researchers better understand the nature of a
patient's cancer, genetic disease, or infection. This system is designed for
laboratories performing highly sensitive and precise DNA and RNA analysis in
oncology and infectious diseases
Some players in the
global lung cancer diagnostics market are F. Hoffmann-La Roche Ltd., Thermo
Fisher Scientific Inc., Abbott, Quest Diagnostics Incorporated, Biodesix, Amoy
Diagnostics Co., Ltd., Bio-Rad Laboratories, Inc., Biocartis, Boditech Med
Inc., Danaher, Vela Diagnostics, DiaSorin S.p.A., Exact Sciences UK, Ltd. (a
subsidiary of Exact Science Corporation), 20/20 Gene Systems, Guardant Health,
Inc., Inivata Ltd., LalPathLabs.com, LungLife AI, Inc., MedGenome, Myriad
Genetics, Inc., NeoGenomics Laboratories, NanoString, Nanoentek, Oncocyte Corporation,
PerkinElmer Inc., PlexBio, QIAGEN, Siemens Healthcare GmbH, and Veracyte, Inc.
among others.
Global Lung Cancer
Diagnostics Market Scope
The global lung cancer diagnostics market is categorized
into five notable segments based on product type, test type, cancer type, end
user, and distribution channel. The growth amongst these segments will help you
analyse meager growth segments in the industries and provide the users with a
valuable market overview and market insights to make strategic decisions to
identify core market applications.
Product Type
·
Instruments
·
Consumables & Accessories
On the basis of product type, the global lung cancer
diagnostics market is segmented into instruments, consumables &
accessories.
Test Type
·
Biomarkers Tests
·
Imaging Test
·
Biopsy
·
Blood Test
·
Others
On the basis of test type, the global lung cancer
diagnostics market is segmented into imaging test, biomarkers test, biopsy,
blood test, and others.
Cancer Type
·
Non-Small Cell Lung Cancer
·
Small Cell Lung Cancer
On the basis of cancer type, the global lung cancer
diagnostics market is segmented into non-small cell lung cancer and small cell
lung cancer.
End User
·
Hospital
·
Associated Labs
·
Independent Diagnostic Laboratories
·
Diagnostic Imaging Centers
·
Cancer Research Institutes
·
Others
On the basis of end user, the global lung cancer diagnostics
market is segmented into hospital, associated labs, independent diagnostics
laboratories, diagnostic imaging centers, cancer research institutes, and
others.
Distribution Channel
·
Direct Tender
·
Retail Sales
On the basis of distribution channel, the global lung cancer
diagnostics market is segmented into direct tender and retail sales.
Browse a Detailed
Summary of the Global Lung Cancer Diagnostics Market Research Report @ https://www.databridgemarketresearch.com/reports/global-lung-cancer-diagnostics-market
This Market
Intelligence Report Analyses Some of the Most Crucial Concerns:
•
How will the major segments of this
international market develop over the next few years?
•
Who are the major players that will dominate the
market in the future?
•
When it comes to this industry, who are the top
suppliers and producers?
•
How have the most successful companies in the
industry planned for future growth and expansion?
•
In what sectors might we expect to see the
greatest increase in demand over the coming years?
•
How many distinct subsets of buyers make up this
market?
•
Which regional powerhouse do you foresee as
becoming the largest player in the international market?
•
Does a new coronavirus pandemic have any
consequences?
•
In what ways are established actors stymied by
the entry of newcomers, and how may they be overcome?
Browse More Reports
Global Non-Small Cell Lung Cancer
Diagnostics Market – Industry Trends and Forecast to 2028
North America Non-Small Cell Lung Cancer
Diagnostics Market – Industry Trends and Forecast to 2028
Europe Non-Small Cell Lung Cancer
Diagnostics Market – Industry Trends and Forecast to 2028
Asia-Pacific Non-Small Cell Lung Cancer
Diagnostics Market – Industry Trends and Forecast to 2028
About Data Bridge
Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational
management consulting firm with offices in India and Canada. As an innovative
and neoteric market analysis and advisory company with unmatched durability
level and advanced approaches. We are committed to uncover the best consumer
prospects and to foster useful knowledge for your company to succeed in the
market.
Data Bridge Market Research is a result of sheer wisdom and
practice that was conceived and built-in Pune in the year 2015. The company
came into existence from the healthcare department with far fewer employees
intending to cover the whole market while providing the best class analysis.
Later, the company widened its departments, as well as expands their reach by
opening a new office in Gurugram location in the year 2018, where a team of
highly qualified personnel joins hands for the growth of the company. “Even in
the tough times of COVID-19 where the Virus slowed down everything around the
world, the dedicated Team of Data Bridge Market Research worked round the clock
to provide quality and support to our client base, which also tells about the
excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com
Comments
Post a Comment